Natera Inc (NTRA) - Total Liabilities
Based on the latest financial reports, Natera Inc (NTRA) has total liabilities worth $836.00 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NTRA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Natera Inc - Total Liabilities Trend (2012–2025)
This chart illustrates how Natera Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see NTRA current and non-current assets.
Natera Inc Competitors by Total Liabilities
The table below lists competitors of Natera Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Argen-X
BR:ARGX
|
Belgium | €1.61 Billion |
|
Erste Group Bank AG
VI:EBS
|
Austria | €419.45 Billion |
|
Celestica Inc.
TO:CLS
|
Canada | CA$7.30 Billion |
|
Larsen & Toubro Limited
F:LTO
|
Germany | €3.24 Trillion |
|
CITIC Securities Co Ltd
SHG:600030
|
China | CN¥1.90 Trillion |
|
Vistra Energy Corp
NYSE:VST
|
USA | $32.80 Billion |
|
AutoZone Inc
NYSE:AZO
|
USA | $23.70 Billion |
|
Ambev S.A.
SA:ABEV3
|
Brazil | R$54.79 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Natera Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Natera Inc (NTRA) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Natera Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Natera Inc (2012–2025)
The table below shows the annual total liabilities of Natera Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $795.62 Million | +70.99% |
| 2024-12-31 | $465.31 Million | -31.20% |
| 2023-12-31 | $676.37 Million | -1.79% |
| 2022-12-31 | $688.73 Million | +18.10% |
| 2021-12-31 | $583.18 Million | +30.78% |
| 2020-12-31 | $445.92 Million | +46.71% |
| 2019-12-31 | $303.94 Million | +28.79% |
| 2018-12-31 | $236.01 Million | +24.74% |
| 2017-12-31 | $189.20 Million | +81.56% |
| 2016-12-31 | $104.20 Million | +29.49% |
| 2015-12-31 | $80.47 Million | -72.72% |
| 2014-12-31 | $294.96 Million | +27.56% |
| 2013-12-31 | $231.23 Million | +66.47% |
| 2012-12-31 | $138.90 Million | -- |
About Natera Inc
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehe… Read more